Sultan Reshamwala signed Raritan Pharmaceuticals' 2024 Form 5500 as plan administrator.
Signer names are public record from the Form 5500 e-signature.
Raritan Pharmaceuticals' EIN is 01-0680942.
Download the official 2024 Form 5500 (PDF) for Raritan Pharmaceuticals from the U.S. Department of Labor's EFAST2 system.
Download the official 2024 Form 5500 (PDF)Raritan Pharmaceuticals' plan includes profit-sharing, ERISA 404(c) participant direction, a 401(k) feature, a default investment (QDIA).
Holdings are itemized directly on this plan's Schedule of Assets, below.
| Name | EIN | Location | Relation | Direct comp | Indirect comp |
|---|---|---|---|---|---|
| PAYCHEX, INC. | 16-1124166 | ROCHESTER, NY | RECORDKEEPER | $16K | — |
| Name | EIN | Location | Relation | Direct comp | Indirect comp |
|---|---|---|---|---|---|
| MERRILL LYNCH, PIERCE, FENNER | 13-5674085 | NEW YORK, NY | INVESTMENT ADVISORY PLAN | $15K | — |
| PI | % of plan | |||||
|---|---|---|---|---|---|---|
| [Assets held in registered investment companies (mutual funds)] | Other | — | — | $6.0M | 83.5% | |
| [Assets held in interest-bearing cash] | Other | — | — | $1.2M | 16.2% | |
| [Assets held in participant loans] | Other | — | — | $22K | 0.3% |
